Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,561 to 1,580 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia. | Hum Mol Genet | 2021 | 33432325 | PubTator, text mining | PubMed |
| A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients. | Sci Rep | 2021 | 33432021 | PubTator, text mining | PubMed |
| Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients. | Hum Genomics | 2021 | 33431054 | PubTator, text mining | PubMed |
| Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma. | Cancers (Basel) | 2021 | 33429865 | PubTator, text mining | PubMed |
| The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited. | Eur Urol | 2021 | 33419682 | PubTator, text mining | PubMed |
| Fast T1 measurement of cortical bone using 3D UTE actual flip angle imaging and single-TR acquisition (3D UTE-AFI-STR). | Magn Reson Med | 2021 | 33404142 | PubTator, text mining | PubMed |
| Severe telomere shortening in Fanconi anemia complementation group L. | Mol Biol Rep | 2021 | 33394227 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| The arrival of personalized genomics in bone marrow failure. | Haematologica | 2021 | 33386715 | PubTator, text mining | PubMed |
| Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report. | Tumori | 2021 | 33345750 | PubTator, text mining | PubMed |
| Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer. | Pathol Res Pract | 2021 | 33341547 | PubTator, text mining | PubMed |
| Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer. | Hum Mutat | 2021 | 33326660 | PubTator, text mining | PubMed |
| Global proteomics of Ubqln2-based murine models of ALS. | J Biol Chem | 2021 | 33277362 | PubTator, text mining | PubMed |
| The financial impact of puerperal infections on patients, carers and public hospitals in two regions in Ghana. | Int J Gynaecol Obstet | 2021 | 33275780 | PubTator, text mining | PubMed |
| Hyper-truncated Asn355- and Asn391-glycans modulate the activity of neutrophil granule myeloperoxidase. | J Biol Chem | 2021 | 33273015 | PubTator, text mining | PubMed |
| Investigating DNA methylation as a potential mediator between pigmentation genes, pigmentary traits and skin cancer. | Pigment Cell Melanoma Res | 2021 | 33248005 | PubTator, text mining | PubMed |
| Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo. | Neoplasia | 2021 | 33246310 | PubTator, text mining | PubMed |
| Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. | Cell Stem Cell | 2021 | 33232662 | PubTator, text mining | PubMed |
| Applying genome-wide CRISPR to identify known and novel genes and pathways that modulate formaldehyde toxicity. | Chemosphere | 2021 | 33189395 | PubTator, text mining | PubMed |
| FANCA, TP53, and del(5q)/RPS14 alterations in a patient with T-cell non-Hodgkin lymphoma and concomitant Fanconi anemia and Li-Fraumeni syndrome. | Cancer Genet | 2021 | 33183999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=79